Matrix Metalloprotease 27: Key Regulator of Tissue Repair and Regeneration

Target Name: MMP27

NCBI ID: G64066

MMP27

Matrix Metalloprotease 27: Key Regulator of Tissue Repair and Regeneration

Matrix metalloprotease (MMP) 27 (MMP27) is a protein that is expressed in a variety of tissues throughout the body, including the liver, heart, kidneys, and intestines. It is a member of the MMP family, which includes proteins that regulate extracellular matrix (ECM) degradation and matrix metalloproteases (MMPs), which are enzymes that break down ECM components.

MMP27 is involved in the regulation of cellular processes that are critical for tissue repair and regeneration, such as the formation of new blood vessels, the development of new tissues, and the regulation of cell signaling pathways. It is also involved in the degradation of ECM components that are damaged or no longer needed, such as damaged proteins, cellular debris, and extracellular matrix components that are no longer supportive of the cell.

MMP27 is a key player in the regulation of matrix metalloproteases (MMPs), which are a group of enzymes that play a critical role in the degradation of ECM components. MMP27 is one of the four known MMP genes that have been identified in humans, and it is the only one that is expressed in the liver.

MMP27 is a 120 amino acid protein that is expressed in a variety of tissues, including the liver, heart, kidneys, and intestines. It is a member of the MMP family, which includes proteins that regulate ECM degradation and MMPs. MMP27 is expressed in many different cell types, including epithelial cells, endothelial cells, pericytes, and immune cells.

MMP27 is involved in a variety of cellular processes that are critical for tissue repair and regeneration. It is involved in the formation of new blood vessels, the development of new tissues, and the regulation of cell signaling pathways. It is also involved in the degradation of ECM components that are damaged or no longer needed.

One of the key functions of MMP27 is its role in the regulation of MMPs. MMP27 is a potentMMP inhibitor, which means that it can inhibit the activity of MMP2,MMP9, and MMP18, the three other known MMP genes that have been identified in humans. This ability to inhibit MMP activity makes MMP27 an attractive drug target for researchers who are interested in the regulation of matrix metalloproteases and their role in tissue repair and regeneration.

In addition to its role in the regulation of MMPs, MMP27 is also involved in the regulation of cellular signaling pathways. It is a critical regulator of the TGF-β pathway, which is a well-known pathway that is involved in the regulation of cell growth, differentiation, and survival. MMP27 is also involved in the regulation of the PI3K/Akt signaling pathway, which is involved in the regulation of cellular signaling pathways that are critical for cell survival and growth.

MMP27 is also involved in the regulation of cellular processes that are critical for tissue repair and regeneration. It is involved in the formation of new blood vessels, the development of new tissues, and the regulation of cell signaling pathways. It is also involved in the degradation of ECM components that are damaged or no longer needed.

One of the key functions of MMP27 is its role in the regulation of MMPs. MMP27 is a potent MMP inhibitor, which means that it can inhibit the activity of MMP2,MMP9, and MMP18, the three other known MMP genes that have been identified in humans. This ability to inhibit MMP activity makes MMP27 an attractive drug target for researchers who are interested in the regulation

Protein Name: Matrix Metallopeptidase 27

Functions: Matrix metalloproteinases degrade protein components of the extracellular matrix such as fibronectin, laminin, gelatins and/or collagens

The "MMP27 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MMP27 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets